Cardlytics (NASDAQ:CDLX – Get Free Report)‘s stock had its “hold” rating reissued by analysts at Needham & Company LLC in a research note issued on Friday,Benzinga reports.
Other equities analysts also recently issued research reports about the company. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Evercore ISI started coverage on Cardlytics in a research note on Friday, October 11th. They set an “in-line” rating and a $4.00 target price for the company. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Cardlytics presently has an average rating of “Hold” and an average price target of $6.92.
Get Our Latest Analysis on Cardlytics
Cardlytics Trading Up 3.3 %
Cardlytics (NASDAQ:CDLX – Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18. The company had revenue of $67.06 million during the quarter, compared to the consensus estimate of $57.77 million. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The company’s quarterly revenue was down 15.1% on a year-over-year basis. During the same quarter last year, the firm posted ($0.26) EPS. On average, equities research analysts anticipate that Cardlytics will post -1.52 EPS for the current fiscal year.
Insiders Place Their Bets
In other Cardlytics news, CEO Amit Gupta sold 22,607 shares of the company’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total value of $87,036.95. Following the transaction, the chief executive officer now directly owns 178,519 shares of the company’s stock, valued at $687,298.15. This represents a 11.24 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Alexis Desieno sold 8,854 shares of Cardlytics stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $3.67, for a total value of $32,494.18. Following the sale, the chief financial officer now directly owns 121,976 shares of the company’s stock, valued at $447,651.92. This represents a 6.77 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 69,007 shares of company stock worth $251,297 over the last three months. Insiders own 4.40% of the company’s stock.
Hedge Funds Weigh In On Cardlytics
Institutional investors and hedge funds have recently modified their holdings of the business. Atom Investors LP acquired a new stake in Cardlytics in the 3rd quarter worth about $33,000. Tallon Kerry Patrick bought a new position in shares of Cardlytics during the fourth quarter worth approximately $37,000. SG Americas Securities LLC acquired a new stake in shares of Cardlytics in the third quarter valued at approximately $45,000. Intech Investment Management LLC bought a new stake in shares of Cardlytics in the third quarter valued at approximately $47,000. Finally, Quadrature Capital Ltd acquired a new stake in Cardlytics during the third quarter worth approximately $63,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.
Cardlytics Company Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Stories
- Five stocks we like better than Cardlytics
- What is the Dow Jones Industrial Average (DJIA)?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Stock Sentiment Analysis: How it Works
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- The Significance of Brokerage Rankings in Stock Selection
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.